Chapter 4: Red cell transfusion to treat anemia in CKD-Reference-Cited by-同舟云学术

Chapter 4: Red cell transfusion to treat anemia in CKD

Published:2012-08 Issue:4 Volume:2 Page:311-316
ISSN:2157-1716
Container-title:Kidney International Supplements
language:en
Short-container-title:Kidney International Supplements

Author:

Publisher

Elsevier BV

Subject

Nephrology

Reference53 articles.

1. Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis;Canadian Erythropoietin Study Group;BMJ,1990

2. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease;Pfeffer;N Engl J Med,2009

3. Lymphocytotoxic antibody responses to transfusions in potential kidney transplant recipients;Opelz;Transplantation,1981

4. USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. National Institutes of Health;USRDS System,2010

5. Physiologic and pathophysiologic effects of anemia;Linman;N Engl J Med,1968

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Roxadustat for the treatment of anemia in patients with lower‐risk myelodysplastic syndrome: Open‐label, dose‐selection, lead‐in stage of a phase 3 study;American Journal of Hematology;2021-11-09

2. Challenging patient phenotypes in the management of anaemia of chronic kidney disease;International Journal of Clinical Practice;2021-08-12

3. Effects of intravenous iron monotherapy for patients with iron deficient anemia undergoing total knee arthroplasty;Arthroplasty;2020-08-03

4. Association of hospital transfusion use and infection‐related rehospitalizations among patients receiving hemodialysis: A retrospective cohort study;Hemodialysis International;2019-12-12

5. Economic and quality of life burden of anemia on patients with CKD on dialysis: a systematic review;Journal of Medical Economics;2019-03-27